metabolic abnormalities in obesity
TRANSCRIPT
![Page 1: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/1.jpg)
Metabolic abnormalities in obesity
Bari Siddiqui M AShyam Prasad B R
![Page 2: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/2.jpg)
Energy Metabolism
• Obesity is caused by excessive intake of calories in relation to energy expenditure over a long period of time.
• The gastro intestinal tract has the capacity to absorb large amounts of nutrients.
• Large increases in body fat can result from even minor but chronic differences between energy intake and energy expenditure
![Page 3: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/3.jpg)
Nutrient and Energy Model of Obesity
Obesity results from increased intake of energy or decreased expenditure of energy, as required by the first law of thermodynamics.
3
Energy Intake
Adipose tissue
Energy Expenditure
![Page 4: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/4.jpg)
Total energy expenditure(TEE) 1. Resting energy expenditure(REE)- represents the
energy expended for normal cellular and organ function under post absorptive resting conditions- 70% of total TEE
2. Energy expended in physical activity – includes both volitional activity like exercise and non volitional activity like muscle contractions, maintaining posture- 20% of TEE
3. Thermic effect of food(TEF) – the energy expended in digestion, absorption and sympathetic nervous system activation after a meal
![Page 5: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/5.jpg)
• Obese individuals have a greater rate of REE due to increased adipose tissue cell mass.
• During non weight bearing activities obese individuals spend the same amount of energy as lean individuals but during weight bearing activities obese individuals spend greater energy on physical activity.
• There is reduction in thermic effect of food due to insulin resistance and blunted sympathetic nervous system activity in obesity
• Diet induced weight loss reduces REE by 15 to 30%
![Page 6: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/6.jpg)
Adipose tissue
• Energy depots that store triglycerides during feeding and release fatty acids during fasting
• Functions as endocrine organ and secretes - leptin - resistin - estrogens - tumor necrosis factor α
![Page 7: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/7.jpg)
Adipocyte formation• Obesity is associated with increased number of adipocytes.• Adipocytes are formed from fibroblast precursor by extra
nuclear factors and signal transduction pathways for differentiation
Very early – Lipo protein lipase(LPL)Early - Methyl Isobutyl Xanthine(MIX) - Dexamethasone - Insulin - Enhancer Binding Protein(EBP)Intermediate – Peroxisome Proliferator Activated Receptor(PRAR)Late – EBP and adipocyte specific gene expression
![Page 8: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/8.jpg)
Triglyceride storage• The major function of adipocytes is storage of
triglycerides • Triglycerides stored within adipose tissue
constitute the body’s major energy reserve• Triglycerides yield 9.3 kcal/g upon oxidation • Stored as oil inside the fat cell• Most of the triglycerides in adipocytes is
derived from chylomicrons and VLDL
![Page 9: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/9.jpg)
Regulation of storage• Lipo protein lipase(LPL) – is a key regulator of
fat cell triglyceride uptake from circulating triglycerides.
• LPL is synthesized by adipocytes.• The interaction of LPL with chylomicrons and
VLDL release fatty acids from plasma triglycerides, which are then taken up by local adipocytes
![Page 10: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/10.jpg)
LIPO PROTIEN LIPASE
Circulating chylomicrons and VLDL
Free fatty acids
ADIPOCYTES
Insulincortisol
TestosteroneGrowth hormoneCatecholaminesTumor necrosis factor
![Page 11: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/11.jpg)
LIPOLYSIS Alterations in adipocyte lipolysis (triglyceride
breakdown) is observed in obesity and results in increased release of fatty acids into the circulation by
1. Hormone sensitive lipase (HSL)2. Adipose triglyceride lipase (ATGL)-ATGL is highly
expressed in white adipose tissue with less expression in skeletal muscle, accounts for 60-70% of triglyceride lipase activity in adipose and appears to be essential for the control of normal weight
![Page 12: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/12.jpg)
HORMONE SENSITIVE LIPASE
Beta Oxidation Esterification
insulin catecholamines
adipocytes
free fatty acids
![Page 13: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/13.jpg)
Lean person obese
Fatty acids derived from adipose tissue lipolysis and dietary intake are transported across the plasma membrane. The majority of fatty acids are directed towards β-oxidation in the mitochondria, where most fatty acids are completely oxidized. A smaller fraction of the fatty acids are esterified to form diglyceride and triglyceride and some fatty acids are converted into ceramide
Increased lipolysis from an enlarged adipose mass increases fatty acid delivery to peripheral tissues. Fatty acid uptake is greater and an increased fraction of the transported fatty acids are directed towards esterification, rather than oxidation. Accordingly, lipid metabolites accumulate in the tissue. A reduced mitochondrial capacity is associated with more incomplete oxidation of fatty acids.
![Page 14: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/14.jpg)
Dysregulation of fatty acid metabolism in obesity
![Page 15: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/15.jpg)
ENDOCRINE FUNCTION• The adipocyte produces and secretes a wide
variety of hormones and cytokines (termed ‘adipokines’) that influence many biological processes, including substrate metabolism.
• Adipose tissue uses adipokines as a communication tool to signal changes in its mass and energy status to other organs that control fuel usage, such as skeletal muscle and liver.
![Page 16: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/16.jpg)
LEPTIN
Leptin is produced by adipose tissue to signal fat storage reserves in the body, and mediates long-term appetitive controls (i.e. to eat more when fat storages are low and less when fat storages are high).
![Page 17: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/17.jpg)
Leptin acts on receptors in the hypothalamus of the brain where it inhibits appetite by
1. counteracting the effects of neuropeptide Y (a potent feeding stimulant secreted by cells in the gut and in the hypothalamus)
![Page 18: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/18.jpg)
2. Counteracting the effects of Anandamide (another potent feeding stimulant that binds to the same receptors as THC, the active ingredient of marijuana); and
3. promoting the synthesis of α-MSH, an appetite suppressant. This inhibition is long-term, in contrast to the rapid inhibition of eating by cholecystokinin (CCK) and the slower suppression of hunger between meals mediated by PYY3-36.
![Page 19: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/19.jpg)
Ghrelin
Ghrelin is produced by the stomach modulating short-term appetitive control (i.e. to eat when the stomach is empty and to stop when the stomach is stretched)
![Page 20: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/20.jpg)
• Ghrelin is secreted mainly by the stomach, • Has paracrine or endocrine effects on GI motility• Circulate in the blood and act on CNS growth
hormone secretagogue receptors (GHS-Rs) inside and outside the blood–brain barrier.
• Known target areas in the CNS include the hypothalamus, the ventral tegmentum and nucleus accumbens, the hippocampus and GHS-R populations in the brainstem area.
• The actions of ghrelin in the CNS contribute to the control of food intake and co-regulate tissue-specific cellular pathways in the periphery, thereby governing glucose, lipid and energy metabolism.
![Page 21: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/21.jpg)
![Page 22: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/22.jpg)
Central pathway While Leptin and Ghrelin are
produced peripherally, they control appetite through their actions on the central nervous system. In particular, they act on the hypothalamus, a region of the brain central to the regulation of food intake and energy expenditure.
![Page 23: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/23.jpg)
There are several circuits within the hypothalamus that contribute to its role in integrating appetite.
• The melanocortin pathway being the most well understood.
• The circuit begins with an area of the hypothalamus, the arcuate nucleus, that has outputs to the lateral hypothalamus (LH) and ventromedial hypothalamus (VMH), the brain's feeding and satiety centers, respectively.
![Page 24: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/24.jpg)
• The Arcuate nucleus contains two distinct groups of neurons.
The first group co-expresses Neuropeptide Y (NPY) and Agouti-related peptide (AgRP) and has stimulatory inputs to the LH and inhibitory inputs to the VMH
![Page 25: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/25.jpg)
The second group coexpresses pro-opiomelanocortin (POMC) and cocaine- and amphetamine-regulated transcript(CART) and has stimulatory inputs to the VMH and inhibitory inputs to the LH
![Page 26: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/26.jpg)
• Consequently, NPY/AgRP neurons stimulate feeding and inhibit satiety, while POMC/CART neurons stimulate satiety and inhibit feeding
• Both groups of arcuate nucleus neurons are regulated in part by leptin. Leptin inhibits the NPY/AgRP group while stimulating the POMC/CART group
![Page 27: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/27.jpg)
Arcuate Nucleus
Paraventricular Nucleus
Lateral Hypothalamus
PeripheralAdipositySignals
Appetite
NPY/AgRP
NPY/AgRP
-a MSH CART
+
OrexinMCH
CRHOxytocin
-a MSH CART
FEEDING CENTER
SATIETY CENTER
LECTIN
![Page 28: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/28.jpg)
SUMMARY
28
BrainBrain
NPYAGRPgalanin
Orexin-Adynorphin
StimulateStimulateα-MSHCRH/UCNGLP-I
CARTNE5-HT
InibitInibit
Central SignalsCentral Signals
Glucose
CCK, GLP-1,Apo-A-IVVagal afferents
Insulin
Ghrelin
Leptin
Cortisol
Peripheral signalsPeripheral signals Peripheral organsPeripheral organs
+
+
Gastrointestinaltract
Adiposetissue
FoodIntake
Adrenal glands
External factorsEmotionsFood characteristicsLifestyle behaviorsEnvironmental cues
BrainBrain
NPYAGRPgalanin
Orexin-Adynorphin
StimulateStimulateα-MSHCRH/UCNGLP-I
CARTNE5-HT
InibitInibit
Central SignalsCentral Signals
Glucose
CCK, GLP-1,Apo-A-IVVagal afferents
Insulin
Ghrelin
Leptin
Cortisol
Peripheral signalsPeripheral signals Peripheral organsPeripheral organs
+
+
+
+
Gastrointestinaltract
Adiposetissue
FoodIntake
Adrenal glands
External factorsEmotionsFood characteristicsLifestyle behaviorsEnvironmental cues
External factorsEmotionsFood characteristicsLifestyle behaviorsEnvironmental cues
![Page 29: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/29.jpg)
Morton G.J., et.al., Nature 443:289-295, 2006
Hedonic CNS Pathways
![Page 30: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/30.jpg)
Morton G.J., et.al., Nature 443:289-295, 2006
Homeostatic CNS Pathways
![Page 31: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/31.jpg)
Genetics
• Leptin gene mutations• Leptin receptor mutations• Prohormone convertase1 gene mutation• Pro-opiomelanocortin gene mutation• Melanocortin 4 receptor gene mutation• SIM1 gene mutation
![Page 32: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/32.jpg)
Medical Complications of Obesity
Pulmonary diseaseabnormal functionobstructive sleep apneahypoventilation syndrome
32
Nonalcoholic fatty liver diseasesteatosissteatohepatitiscirrhosis
Gall bladder disease
Gynecologic abnormalitiesabnormal mensesinfertilityPCOS
Osteoarthritis
Gout
Phlebitisvenous stasis
Cancerbreast, uterus, cervixcolon, esophagus, pancreaskidney, prostate
Severe pancreatitis
CHD Diabetes Dyslipidemia Hypertension
Cataracts
Stroke
![Page 33: Metabolic abnormalities in obesity](https://reader030.vdocuments.mx/reader030/viewer/2022012908/55578243d8b42aa3378b45b6/html5/thumbnails/33.jpg)